MicroRNA‑628‑5p inhibits cell proliferation and induces apoptosis in colorectal cancer through downregulating CCND1

Fei Guo1, Jun Xue1

  • 1Department of General Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei 075061, P.R. China.

Insights

MicroRNA-628-5p is downregulated in colorectal cancer, inhibiting proliferation and inducing apoptosis. Its axis with cyclin D1 (CCND1) suggests miR-628-5p as a potential biomarker for colorectal cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA (miR)-628-5p exhibits antitumor properties in various cancers.
  • The specific function of miR-628-5p in colorectal cancer (CRC) is not well-defined.
  • Understanding miR-628-5p's role is crucial for developing novel CRC therapeutic strategies.

Purpose of the Study:

  • To elucidate the role and underlying mechanism of miR-628-5p in colorectal cancer.
  • To investigate miR-628-5p's impact on CRC cell proliferation and apoptosis.
  • To identify potential therapeutic targets within the miR-628-5p pathway.

Main Methods:

  • Quantitative PCR (RT-qPCR) and western blotting to assess gene expression.
  • Colony formation assays and flow cytometry for proliferation and apoptosis analysis.
  • Bioinformatic prediction (TargetScan) and dual-luciferase reporter assays to identify miR-628-5p targets.

Main Results:

  • miR-628-5p expression was significantly downregulated in colorectal cancer tissues and cell lines.
  • Overexpression of miR-628-5p inhibited proliferation and induced apoptosis in HT-29 cells.
  • Cyclin D1 (CCND1) was identified as a direct target of miR-628-5p, promoting proliferation and suppressing apoptosis; these effects were reversed by miR-628-5p mimics.

Conclusions:

  • Colorectal cancer progression is potentially regulated by the miR-628-5p/CCND1 axis.
  • miR-628-5p demonstrates potential as a diagnostic and prognostic biomarker for colorectal cancer.
  • Targeting the miR-628-5p/CCND1 pathway may offer a novel therapeutic approach for colorectal cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K